Case Study: a top-5 biopharma operationalizes its digital twin with Invert

a top-5 biopharma operationalizes its digital twin in under a month with Invert

The customer, a top-5 biopharma company, had invested over $2M in a bioprocess digital twin for upstream development. Despite the model being functional, it was blocked because live run data from its Ambr250 bioreactors was inaccessible; the system was isolated, requiring manual data transfer and reconciliation, and its parameters were inconsistent across instruments, preventing the digital twin from operating.

Invert solved this by implementing a direct OPC and file-based integration with the Ambr250, creating a unified data namespace and automating the linkage of time-series data with offline instrument results and ELN metadata. This solution was deployed in days, unlocking the $2M digital twin investment. The integration went live in under a month instead of a projected six, shifting data science resources from manual reconciliation to development and accelerating process optimization with real-time data.

Top-5 Biopharma With Active Digital Twin Program